Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
The Journal of General Physiology|January 1, 1996
CFTR: the nucleotide binding folds regulate the accessibility and stability of the activated stateD J Wilkinson, M K Mansoura, P Y Watson, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|May 23, 2015
Linking Exposures of Particles Released From Nano-Enabled Products to Toxicology: An Integrated Methodology for Particle Sampling, Extraction, Dispersion, and DosingAnoop K Pal, Christa Y Watson, Sandra V Pirela, et al.Journal of Magnetic Resonance Imaging : JMRI|March 14, 2000
Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: a possible marker of vascular tortuosityA Kassner, D J Annesley, X P Zhu, et al.Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|October 1, 2010
Cross-visit tumor sub-segmentation and registration with outlier rejection for dynamic contrast-enhanced MRI time series dataG A Buonaccorsi, C J Rose, J P B O'Connor, et al.Bioinformatics (Oxford, England)|March 17, 2018
A new method for the high-precision assessment of tumor changes in response to treatmentP D Tar, N A Thacker, M Babur, et al.Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|November 30, 2007
Quantifying heterogeneity in dynamic contrast-enhanced MRI parameter mapsC J Rose, S Mills, J P B O'Connor, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|January 1, 2016
Screening for Chemical Toxicity Using Cryopreserved Precision Cut Lung SlicesChrista Y Watson, Flavia Damiani, Sumati Ram-Mohan, et al.ACS Nano|October 22, 2024
Graphene Phase Modulators Operating in the Transparency RegimeHannah F Y Watson, Alfonso Ruocco, Matteo Tiberi, et al.British Journal of Cancer|June 16, 2011
DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6J P B O'Connor, C J Rose, A Jackson, et al.Magnetic Resonance in Medicine|March 26, 2011
Comparison of dynamic contrast-enhanced MRI and dynamic contrast-enhanced CT biomarkers in bladder cancerJ H Naish, D M McGrath, L J Bains, et al.Pageof 5